Filer Snapshot

Casi DeYoung

CIK 0001652066. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Individual

Total filings

4

Latest filing

27 Jan 2026

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: Forms 3/4/5 owner position for STTK. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Largest parsed holding

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Source: SEC Forms 3/4/5

4 filed on 27 Jan 2026 for CIK 0001652066.

View Source Filing
SEC ownership signals 1 fact
SEC ownership summary

Parsed filing values

Bars compare filing families separately; they should not be added together as one total.

Forms 3/4/5 positions$304.9K

Reporting-owner positions when a value can be estimated.

Forms 3/4/5 position value

$304.9K

Estimated from parsed Forms 3/4/5 when the filing discloses enough data.

Top issuer positions

Largest parsed issuer positions across ownership filing types.

STTK
How to read filing-family values
  • Filing families stay separate: 13F portfolio value, 13D/G large stakes, and Forms 3/4/5 owner positions should not be blended into one total.
  • Use the linked research paths to verify each signal against the original SEC filing.
Filer identity 1 fact
Business address
C/O Mirna Therapeutics, Inc., 2150 Woodward St., Suite 100, Austin, TX, 78744

Filer intelligence

What SEC filings say about Casi DeYoung

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Quick read

  • Forms 3/4/5 show insider context for STTK worth $304.9K.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

Open
13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 1 rows

Officer, director, and 10% owner holdings or transactions.

Open

Forms 3/4/5 insider context

STTK

25 Jan 2026 · Chief Business Officer

$304.9K

Latest update

What changed recently for Casi DeYoung

Ownership report updated

Latest ownership report period: 25 Jan 2026. Open the source-backed page to inspect the fresh filing or facts context.

Update date

27 Jan 2026

Page type

Ownership filings

Latest period

25 Jan 2026

Ownership context was refreshed from SEC Forms 3/4/5 filed on 27 Jan 2026.

SEC filing record

CIK 0001652066 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
4
First seen
12 Jan 2022
Latest filing
27 Jan 2026
Entity
Individual

Latest Filings

Showing the latest 4 of 4 SEC filings for Casi DeYoung.

4

4 filing

Filing date
27 Jan 2026
Reporting date
25 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Jan 2023
Reporting date
25 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Jan 2023
Reporting date
10 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Jan 2022
Reporting date
10 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .